These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 4394125)
1. Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity. Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y J Antibiot (Tokyo); 1970 Mar; 23(3):137-48. PubMed ID: 4394125 [No Abstract] [Full Text] [Related]
2. [Study of antibacterial and antifungal activity of lutenurine in experiments in vitro]. Vichkanova SA; Adgina VV; Fedorchenko TS; Rudinchik MA Farmakol Toksikol; 1969; 32(5):620-3. PubMed ID: 4391463 [No Abstract] [Full Text] [Related]
3. Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. Finland M Ann Intern Med; 1972 Jun; 76(6):1009-36. PubMed ID: 4402139 [No Abstract] [Full Text] [Related]
4. Production of antibiotics by Epidermophyton floccosum. 4. The antibacterial activity of the "Epidermophyton factor" (EPF) compared with that of some steroid antibiotics. Wallerström A Acta Pathol Microbiol Scand; 1969; 77(3):465-76. PubMed ID: 4392805 [No Abstract] [Full Text] [Related]
6. [On the effect of hexetidine in vitro]. Linzenmeier G Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760 [No Abstract] [Full Text] [Related]
7. [Bacteriological studies on penimepicycline]. Nakazawa S; Ono N; Mekata I; Kawabe H; Nishino T Jpn J Antibiot; 1969 Feb; 22(1):16-20. PubMed ID: 4389008 [No Abstract] [Full Text] [Related]
8. [Experimental evaluation of the new cephalosporin antibiotic cephacetrile]. Kradolfer F; Ahrens T; Gelzer J; Vischer W; Zimmermann W Arzneimittelforschung; 1974 Sep; 24(9b):1446-51. PubMed ID: 4154769 [No Abstract] [Full Text] [Related]
9. [Study of the chemical composition of aspergin--a metabolite from Aspergillus sp]. Sokolov LB; Alekseeva LE; Kul'bakh VO; Kuznetsova NA; Nyn' VS Antibiotiki; 1971 Jun; 16(6):504-10. PubMed ID: 4398785 [No Abstract] [Full Text] [Related]
10. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined. Bach MC; Finland M; Gold O; Wilcox C J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416 [No Abstract] [Full Text] [Related]
12. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Steigbigel NH; Reed CW; Finland M Am J Med Sci; 1968 Mar; 255():179-95. PubMed ID: 4384524 [No Abstract] [Full Text] [Related]
13. In vitro activity of cefazolin against recent clinical bacterial isolates. Sabath LD; Wilcox C; Garner C; Finland M J Infect Dis; 1973 Oct; 128():Suppl:S320-6. PubMed ID: 4200651 [No Abstract] [Full Text] [Related]
14. [Study of antimicrobial properties and action of rubomycin on the intestinal microflora of laboratory animals]. Pevzner NS; Shapovalova SP Antibiotiki; 1967 Jun; 12(6):523-6. PubMed ID: 4386254 [No Abstract] [Full Text] [Related]
15. [Lincomycin--a new antibiotic]. Primavesi CA Arzneimittelforschung; 1967 Apr; 17(4):500-2. PubMed ID: 4386772 [No Abstract] [Full Text] [Related]
16. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin. Ripa S; Prenna M Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784 [TBL] [Abstract][Full Text] [Related]